Recall map → All recalls → F-1338-2013
Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles. Nexgen Pharma, Inc. · reported 2013-05-01
Terminated This recall has been closed out by the agency.
- Reason for recall
- Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.
- Classification
- Class III
- Recall initiated
- 2013-04-15
- Reported by the agency
- 2013-05-01
- Closed out (terminated)
- 2013-09-06
- Recalling firm
- Nexgen Pharma, Inc.
Colorado Springs, CO
United StatesThis is the firm that issued the recall — commonly a distributor or processor. It is not the origin of contamination.
- Distribution (the agency's own words)
- Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands).
- States we parsed from that text
- AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WYour expansion
The agency wrote a broader phrase; these state names are ours, not theirs. Parse method nationwide, confidence high.
- Food category
- Dietary supplementsderived
Assigned by a reviewed keyword rulebook over the product description, not by the agency.
- Recall type
- Voluntary: Firm initiated
- Recall number
- F-1338-2013
View this record at the agency source →
This page reproduces a record published by the US Food and Drug Administration. It is not real-time: recalls typically appear in FDA's Enforcement Report weeks after they begin — a median of 40 days, see publication lag. For current food safety information consult FDA and USDA FSIS directly.